<DOC>
	<DOC>NCT00520104</DOC>
	<brief_summary>This is an open label, single-center study to determine whether certain nasal medication interact with PMI-150 (intranasal ketamine) 30 mg in healthy adult volunteers and in patients with allergic rhinitis.</brief_summary>
	<brief_title>Determination of Drug Interactions of Certain Nasal Medications With Intranasal Ketamine</brief_title>
	<detailed_description>To assess separately the effects of a nasal vasoconstrictor (oxymetazoline) and of a nasal steroid on the rate and extent of intranasal absorption of PMI-150 30 mg.</detailed_description>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Healthy adults Patients with Allergic Rhinitis Under age 18</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
</DOC>